HK1247827A1 - 局部治療組合物 - Google Patents

局部治療組合物

Info

Publication number
HK1247827A1
HK1247827A1 HK18107274.2A HK18107274A HK1247827A1 HK 1247827 A1 HK1247827 A1 HK 1247827A1 HK 18107274 A HK18107274 A HK 18107274A HK 1247827 A1 HK1247827 A1 HK 1247827A1
Authority
HK
Hong Kong
Prior art keywords
topical composition
healing topical
healing
composition
topical
Prior art date
Application number
HK18107274.2A
Other languages
English (en)
Inventor
Melwyn Abreo
Carol Mcbride
Talal Sheena
Original Assignee
Florengale Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florengale Llc filed Critical Florengale Llc
Publication of HK1247827A1 publication Critical patent/HK1247827A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18107274.2A 2015-01-27 2018-06-04 局部治療組合物 HK1247827A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562108492P 2015-01-27 2015-01-27
PCT/US2016/015135 WO2016123223A1 (en) 2015-01-27 2016-01-27 Healing topical composition

Publications (1)

Publication Number Publication Date
HK1247827A1 true HK1247827A1 (zh) 2018-10-05

Family

ID=56544280

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107274.2A HK1247827A1 (zh) 2015-01-27 2018-06-04 局部治療組合物

Country Status (9)

Country Link
US (2) US10682324B2 (zh)
EP (1) EP3250196A4 (zh)
JP (1) JP2018503689A (zh)
AU (1) AU2016211605A1 (zh)
CA (1) CA2974011A1 (zh)
CL (1) CL2017001913A1 (zh)
HK (1) HK1247827A1 (zh)
PE (1) PE20180026A1 (zh)
WO (1) WO2016123223A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10293012B2 (en) 2017-05-04 2019-05-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods of using extracts of melissa officinalis against filoviruses
WO2018208739A1 (en) * 2017-05-08 2018-11-15 Thomas Cahill Pharmaceutical compositions comprising caffeic acid chelates
US11166982B2 (en) 2018-10-03 2021-11-09 Harold H. Simeroth Multi-type stem cell activation with nano silver
ES2759400A1 (es) * 2018-11-07 2020-05-08 Consejo Superior Investigacion INHIBIDORES DE TGF-ß1 Y PRODUCTORES DE ENDOGLINA PARA SU USO EN EL TRATAMIENTO DE EPIDERMOLISIS BULLOSA
JP7373794B2 (ja) 2019-11-15 2023-11-06 デンカ株式会社 没食子酸又は没食子酸結合化合物を含有する液剤
CN113051713B (zh) * 2021-03-01 2023-03-21 东方电气集团科学技术研究院有限公司 基于图像灰度共生矩阵多特征提取的复合材料老化预测方法
WO2024050405A1 (en) * 2022-08-30 2024-03-07 Green Shawn J Compositions and methods for improving nitric oxide levels in intraoral, nasal and/or nasopharyngeal area

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2527757B2 (ja) * 1987-07-17 1996-08-28 リ−・ロイ・モ−ガン 皮膚の炎症を減少させる化合物およびその組成物
DE3822096A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Stabilisierte arzneimittelzubereitung
TW222591B (zh) 1991-08-30 1994-04-21 Procter & Gamble
US5451405A (en) 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
US5691380A (en) * 1995-06-29 1997-11-25 The Procter & Gamble Company Stable n-acetylcysteine compositions and methods for treating human skin therewith
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
IN2000KO00299A (zh) * 1999-05-28 2005-11-18 Johnson & Johnson Consumer
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
US7374772B2 (en) * 2002-11-07 2008-05-20 Bommarito Alexander A Topical antifungal treatment
AU2006238888A1 (en) * 2005-04-21 2006-11-02 Glenn A. Goldstein N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
JP4954531B2 (ja) * 2005-10-31 2012-06-20 一丸ファルコス株式会社 ペルオキシソーム増殖剤応答性受容体活性化剤
US20070149442A1 (en) * 2005-12-13 2007-06-28 Byron Rubin Non-hygroscopic compositions of enterostatin
AU2006326034A1 (en) * 2005-12-14 2007-06-21 Zars Pharma, Inc. Flux-enabling compositions and methods for dermal delivery of drugs
US8287846B2 (en) 2006-07-25 2012-10-16 Zambon S.P.A. Cosmetic or dermatological preparations comprising N-acetylcysteine
WO2009031318A1 (ja) * 2007-09-05 2009-03-12 Kowa Co., Ltd. 鎮痛・抗炎症剤含有外用剤
GB2470040A (en) 2009-05-06 2010-11-10 Systagenix Wound Man Ip Co Bv Wound dressing material comprising N-acetyl cysteine
JP2012533559A (ja) * 2009-07-15 2012-12-27 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ アセトアミノフェンの治療効果を改善するためのｎ−アセチルシステイン組成物および方法
EP2397125A1 (en) * 2010-06-15 2011-12-21 Histocell, S.L. Antioxidant composition
WO2013138744A1 (en) * 2012-03-16 2013-09-19 M. Alphabet 1, Llc Compositions for the treatment of skin disorders
CL2014003326A1 (es) 2014-12-05 2015-03-20 Univ Chile Formulación antioxidante inyectable de uso intravenoso de ascorbato de sodio - en altas dosis, y n-acetilcisteína como agentes oxidantes, y deferoxamina como agentes quelante de hierro, más excipientes farmacéuticos; método para su administración y uso en prevenir el daño por repertfusión en pacientes con inferto agudo del miocardío, sometidos a angioplastia caronaria primaria; y kit que la contiene.

Also Published As

Publication number Publication date
PE20180026A1 (es) 2018-01-09
US20180015060A1 (en) 2018-01-18
CA2974011A1 (en) 2016-08-04
CL2017001913A1 (es) 2018-04-27
US20210015777A1 (en) 2021-01-21
US10682324B2 (en) 2020-06-16
JP2018503689A (ja) 2018-02-08
EP3250196A4 (en) 2018-09-26
AU2016211605A1 (en) 2017-08-10
EP3250196A1 (en) 2017-12-06
WO2016123223A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
IL282304A (en) Pharmaceutical preparations for local use
EP3334403A4 (en) TOPICAL COMPOSITIONS
IL258997B (en) Honey-cannabinoid therapeutic composition
ZA201800080B (en) Topical retinoid compositions
GB2544342B (en) Compositions for application to wounds
EP3302439A4 (en) Therapeutic composition
HK1247827A1 (zh) 局部治療組合物
EP3397239A4 (en) TOPICAL COMPOSITIONS
HK1231396A1 (zh) 外用組合物
SG11202000615VA (en) Topical composition
SG11201706938XA (en) Topical formulation
GB201506526D0 (en) Medicinal composition
IL268374A (en) Topical compounds
HK1246202A1 (zh) 潤膚劑組合物
GB201400647D0 (en) Topical composition
IL272944A (en) local preparations
IL261571B (en) Local anesthetic
HK1257847A1 (zh) 化妝品組合物
HK1247082A1 (zh) 化妝品組合物
GB201713160D0 (en) Topical composition
IL252933A0 (en) Waterless cosmetic preparation for local application
EP3322482C0 (en) TOPICAL CIPROFLOXACIN COMPOSITIONS
GB201513108D0 (en) Topical composition
GB201701970D0 (en) Topical composition
GB201608190D0 (en) Topical composition